COHEN RAYMOND W 4
4 · Axonics, Inc. · Filed Jul 25, 2024
Insider Transaction Report
Form 4
Axonics, Inc.AXNX
COHEN RAYMOND W
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-07-24$14.19/sh+25,771$365,690→ 214,606 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-07-24−25,771→ 196,451 totalExercise: $14.19Exp: 2029-01-30→ Common Stock (25,771 underlying) - Exercise/Conversion
Common Stock
2024-07-24$25.82/sh+78,125$2,017,188→ 292,731 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-07-24−78,125→ 0 totalExercise: $25.82Exp: 2029-12-12→ Common Stock (78,125 underlying)
Footnotes (2)
- [F1]These options were granted on December 12, 2019 and are fully vested.
- [F2]These options were granted on January 30, 2019 and are fully vested.